DEF: Beyond Meat Seeks Shareholder Approval Amid Debt Restructuring

Sentiment:

Special Meeting Proxy Statement 17 October 2025 4:21 PM

Beyond Meat calls a Special Meeting to approve critical proposals, including a massive share increase and potential reverse stock split, following a significant debt exchange that caused substantial shareholder dilution.

Delay expectedThe board of directors may not effectuate a reverse stock split for a period of 120 days after October 15, 2025 (Early Release Date).The board may also not effectuate a reverse stock split during the period beginning on the Early Release Date and ending on the date that is 180 days after October 15, 2025 (Final Release Date), unless specific conditions related to Nasdaq minimum bid price are met or a delisting notice is received.

Capital raiseThe Exchange Offer itself is a significant capital restructuring, exchanging $1.15 billion in Existing Notes for a combination of New Notes and New Shares.Proposal No. 3 to increase authorized shares of Common Stock from 500,000,000 to 3,000,000,000 is explicitly stated to provide greater flexibility for 'raising additional capital and other general corporate purposes'.The company's ability to settle New Notes obligations in Common Stock (if proposals are approved) rather than cash is crucial for preserving cash flow, indicating a need to manage liquidity and potentially avoid future cash raises for debt repayment.

Worse than expectedThe company's net revenues decreased by 4.9% in 2024, indicating continued sales challenges.Despite improvements in net loss and gross margin, the company continues to generate overall losses since inception.Executive officers received zero payouts under the 2024 Executive Incentive Bonus Plan, as threshold performance goals for key financial metrics (net revenues, free cash flow, gross margin, operating expenses) were not achieved.The realizable value of stock options granted to NEOs fell to zero and RSUs to approximately 38% of their grant-date target value by the end of 2024, reflecting poor stock performance.The necessity of a significant debt exchange, substantial shareholder dilution, and the need for a reverse stock split to maintain Nasdaq listing all point to a company in a challenging financial position, requiring reactive measures rather than proactive growth.

Summary

A Special Meeting of Stockholders is scheduled for November 19, 2025, to consider five key proposals related to the company's capital structure and equity plans.
The meeting follows an Exchange Offer where Beyond Meat exchanged $1.15 billion of 0% Convertible Senior Notes due 2027 for new 7.00% Convertible Senior Secured Second Lien PIK Toggle Notes due 2030 and common stock.
On October 15, 2025, $1,114,603,000 (96.92%) of the Existing Notes were tendered and cancelled, resulting in the issuance of $196,217,000 in New Notes and 316,150,176 New Shares.
An additional $12.5 million in New Notes was issued as a 'SteerCo Premium', bringing the total New Notes outstanding to $208,717,000 (or $215.0 million assuming 100% participation).
Proposal 1 seeks approval for the potential issuance of shares exceeding 20% of outstanding common stock for New Notes conversion/equitization, as required by Nasdaq Listing Rule 5635(d).
Proposal 2 requests approval for the Restated 2018 Equity Incentive Plan to increase authorized shares for issuance, including for Management Incentive Plan (MIP) Awards to key employees.
Proposal 3 aims to increase the authorized shares of Common Stock from 500,000,000 to 3,000,000,000 to support the New Notes conversion and the Restated Plan, as the company currently lacks sufficient authorized shares.
Proposal 4 asks for approval of a series of 30 alternate amendments to effect a reverse stock split (ratios from 1-for-10 to 1-for-150) and a proportionate reduction in authorized shares, primarily to maintain Nasdaq listing compliance.
Proposal 5 seeks approval for one or more adjournments of the Special Meeting if necessary to solicit additional proxies.
Existing Noteholders holding 96.92% of the aggregate outstanding principal amount of the Existing Notes have entered into voting agreements to support all proposals.
The company reported a net loss of $160.3 million in 2024, an improvement from $338.1 million in 2023, on net revenues of $326.5 million, a 4.9% decrease from $343.4 million in 2023.
Gross profit significantly improved to $41.7 million in 2024 from a loss of $82.7 million in 2023, with gross margin at 12.8% in 2024 compared to -24.1% in 2023.
Net cash used in operating activities improved to $98.8 million in 2024 from $107.8 million in 2023.
Executive officers received zero payouts under the 2024 Short-Term Incentive (STI) Plan due to not achieving threshold funding goals for net revenues, free cash flow, gross margin, and operating expenses.
The realizable value of CEO stock options fell to zero and RSUs to approximately 38% of grant-date target by the end of 2024.

Sentiment

Score: 3

Explanation: The sentiment is negative due to substantial shareholder dilution, ongoing net losses, the necessity of a debt restructuring to avoid maturity obligations, and the need for a reverse stock split to maintain Nasdaq listing. While some financial metrics showed improvement year-over-year, the overall context indicates a company in a precarious financial position requiring significant reactive measures.

Positives

The Exchange Offer is intended to address future debt repayment obligations related to the Existing Notes in a timely and organized manner, providing an enhanced capital structure and strengthening the balance sheet.
Net loss improved significantly to $160.3 million in 2024 from $338.1 million in 2023.
Gross profit saw a substantial increase to $41.7 million in 2024 from a loss of $82.7 million in 2023.
Gross margin improved to 12.8% in 2024 from a negative 24.1% in 2023.
Operating expenses decreased by 23.7% to $197.8 million in 2024 from $259.2 million in 2023.
Net cash used in operating activities improved to $98.8 million in 2024 from $107.8 million in 2023.
Adjusted EBITDA loss improved to $101.7 million in 2024 from $269.2 million in 2023.
The company has implemented cost-reduction initiatives, including workforce reductions and optimization of manufacturing capacity.
The CEO pay ratio decreased from 83:1 in 2023 to 64:1 in 2024, primarily due to a decrease in the value of equity awards granted to the CEO.

Negatives

The early settlement of the Exchange Offer has resulted in substantial dilution to existing holders of Common Stock.
Assuming 100% participation, Existing Noteholders would own approximately 81.0% of the issued and outstanding shares of Common Stock immediately following the Closing Date.
Further dilution is expected if the New Notes convert into shares of Common Stock, potentially leading to Existing Noteholders owning approximately 87.7% of outstanding shares.
The New Notes include provisions for payment-in-kind (PIK) interest and mandatory equitizations that could result in additional dilution.
The company currently does not have enough authorized shares of Common Stock to support the issuance of shares required for the New Notes conversion or the Restated Plan.
Executive officers received zero payments under the 2024 Executive Incentive Bonus Plan due to failure to meet threshold performance goals.
The realizable value of stock options granted to NEOs fell to zero by the end of 2024, and annual RSUs fell to approximately 38% of their grant-date target value.
The company continues to generate losses since its inception, with a net loss of $160.3 million in 2024.
Net revenues decreased by 4.9% year-over-year in 2024, driven by weak demand in the plant-based meat category and increased competition.
Failure to approve Proposal 1 and 3 would require cash settlement of New Notes obligations, reducing available cash flow and potentially impairing the ability to satisfy indebtedness, leading to risks of insolvency or bankruptcy.
Failure to approve Proposal 2 and 3 would limit the company's ability to grant necessary equity awards to attract and retain key personnel, further diluting the value of existing equity incentives.

Risks

If stockholders do not approve Proposal No. 1 (Nasdaq 5635(d) Proposal) and Proposal No. 3 (Authorized Share Increase Proposal), the company will be required to satisfy obligations under the New Notes (conversion, make-whole amounts, equitizations, accrued interest) in cash.
There is no assurance that the company will have sufficient cash to settle such obligations and support operations if cash settlement is required.
A requirement to pay cash could reduce available cash flow, limit cash for operations, and adversely affect business, financial condition, and results of operations.
Insufficient funds to repay indebtedness could lead to significant reductions, reorganization, discontinuation, or shutdown of operations, potentially causing insolvency or bankruptcy.
Absent approval of Proposal No. 1 and No. 3, the company will have limited financial and corporate flexibility, which could have a material adverse effect on its financial condition.
If Proposal No. 2 (Restated Plan Proposal) and/or the Closing Date does not occur, the company will have a limited number of shares available for future grants under the Existing Plan, hindering its ability to attract and retain key personnel.
The substantial dilution from the Exchange Offer and potential future dilution from New Notes conversion could make the equity incentive program non-competitive for long-term incentives.
Failure to approve the reverse stock split (Proposal No. 4) could lead to the company's Common Stock failing to meet the Nasdaq minimum bid price requirement of $1.00 per share, risking delisting.
Delisting from Nasdaq would significantly and negatively affect the company's ability to obtain alternative debt or equity financing.
A reverse stock split may result in some stockholders owning 'odd lots' (less than 100 shares), which may be more difficult to sell and incur higher brokerage commissions.

Future Outlook

The company's operating environment continues to be affected by uncertainty related to macroeconomic issues, including ongoing weakened demand in the plant-based meat category, inflation, higher interest rates, and potential recessionary concerns. The company is focused on sustainable long-term growth through margin recovery, operating expense reduction, inventory management, and focusing on near-term growth drivers while supporting strategic long-term partners. The board believes the proposed actions are necessary to maintain financial flexibility and Nasdaq listing compliance.

Management Comments

The Exchange Offer is intended to address future debt repayment obligations related to the Existing Notes in a timely and organized manner prior to their maturity, provide the Company with an enhanced capital structure and strengthen the Company’s balance sheet.
We currently do not have enough authorized shares of Common Stock to support the issuance of Common Stock that will be issuable or may become issuable upon conversion of the New Notes or under the Restated Plan.
Increasing the number of authorized shares of Common Stock will provide us with greater flexibility in considering and planning for current and future corporate needs, including raising additional capital and other general corporate purposes.
We believe it is beneficial to provide the Board with the authority and flexibility to effect a reverse stock split, if and when needed, in the event it determines that a reverse stock split is in the best interests of the Company and our stockholders, including in order to maintain the Nasdaq listing of our Common Stock.
Equity awards are crucial for staying competitive in our industry and essential for attracting and retaining highly qualified employees in a challenging labor market.

Industry Context

The company operates in a challenging environment characterized by prolonged softness in demand within the plant-based meat category, increased competition, and macroeconomic issues such as inflation and higher interest rates. These factors have negatively impacted the company's net revenues and overall financial performance, necessitating significant cost-reduction initiatives and capital structure adjustments.

Comparison to Industry Standards

The company's human capital management and compensation committee revised its peer group for compensation benchmarking to include only food and beverage companies within a relevant size range, removing biotechnology, pharmaceuticals, life sciences, and high-growth companies, to better align with the company's slowing growth rate and executive talent competitors.
The company's equity run rate and annual dollar spend for LTI participants were above the 75th percentile of food and beverage peers in mid-2024, primarily due to a lower stock price.
The human capital management and compensation committee generally seeks to target total direct compensation within the 50th to 60th percentiles of peer group companies, with total cash compensation at the 50th percentile and long-term incentive compensation at the 50th to 75th percentile.

Management Changes

Role	Previous Person	New Person	Effective Date	Reason
Director (Class III)	Ethan Brown		2025-10-15	Resignation in connection with the early settlement of the Exchange Offer; continues as President and CEO.
Director (Class II)	Nandita Bakhshi		2025-10-15	Resignation in connection with the early settlement of the Exchange Offer.
Director (Class I to Class II)	C. James Koch (Class I)	C. James Koch (Class II)	2025-10-15	Resigned from Class I and simultaneously appointed to Class II seat vacated by Ms. Bakhshi.
Director (Class I) and Audit Committee Member		Alexandre Zyngier	2025-10-15	Appointment pursuant to the Transaction Support Agreement.
Director (Class III) and Human Capital Management and Compensation Committee Member		Raphael (Ray) Thomas Wallander	2025-10-15	Appointment pursuant to the Transaction Support Agreement.
Chair of Nominating and Corporate Governance Committee		Joshua M. Murray	2025-10-15	Appointment as a result of Ms. Bakhshi's resignation.
Interim Chief Transformation Officer		John Boken	2025-08	Appointed as part of an engagement letter with AlixPartners, LLP.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Amendment and Restatement of Equity Incentive Plan	Board approved the Restated 2018 Equity Incentive Plan to increase authorized shares for issuance, including for MIP Awards to key employees. This plan was effective immediately, subject to the Closing Date and stockholder approval.	2025-09-28	Aims to retain and incentivize key employees in light of substantial dilution from the Exchange Offer, but requires significant additional share authorization.
Amendment to Restated Certificate of Incorporation	Proposal to increase the number of authorized shares of Common Stock from 500,000,000 to 3,000,000,000.	Upon filing (if approved)	Crucial for supporting New Notes conversion and the Restated Plan; provides flexibility for future capital raises but will cause significant dilution.
Reverse Stock Split Authority	Proposal to approve a series of 30 alternate amendments to effect a reverse stock split (1-for-10 to 1-for-150) and proportionate reduction in authorized shares.	Upon filing (if approved and implemented by board)	Intended to maintain Nasdaq listing compliance and improve marketability, but reflects a low share price and can be perceived negatively by investors.
Board Composition Changes	Two directors (Ethan Brown, Nandita Bakhshi) resigned, and two new directors (Alexandre Zyngier, Raphael Thomas Wallander) were appointed, with C. James Koch shifting class. Joshua M. Murray appointed chair of nominating and corporate governance committee.	2025-10-15	Changes made pursuant to the Transaction Support Agreement, potentially reflecting influence from new noteholders and a shift in board oversight.
Stock Ownership Guidelines	Board adopted stock ownership guidelines for outside directors, requiring ownership equal to at least five times the annual cash retainer within five years.	2024-10	Strengthens alignment of interests between non-employee directors and stockholders.
Clawback Policy	Adopted a mandatory clawback policy in compliance with SEC rules and Nasdaq listing standards, allowing recovery of excess incentive-based compensation in case of accounting restatement.	2023-10	Enhances accountability and risk management in executive compensation.
Anti-Hedging and Anti-Pledging Policies	Prohibits employees and directors from engaging in hedging transactions or pledging company stock as collateral for a loan.	In effect	Reduces potential conflicts of interest and promotes alignment with long-term shareholder value.

Legal Proceedings

Operating expenses in 2024 included a $7.5 million accrual related to a consumer class action settlement.

Related Party Transactions

The company entered into a transaction support agreement with certain beneficial owners or nominees, investment managers or advisors for beneficial holders of the Existing Notes (Supporting Noteholders) who held approximately 47% of the aggregate principal amount of the Existing Notes. The company agreed to pay these Supporting Noteholders a non-refundable 'SteerCo Premium' of $12.5 million in aggregate principal amount of New Notes.

Stakeholder Impact

**Shareholders:** Existing common stockholders face substantial and potential further dilution from the Exchange Offer and conversion of New Notes. Their voting power and percentage interest will be significantly reduced. The proposed reverse stock split aims to maintain Nasdaq listing, which is beneficial, but also reflects a low share price. Failure to approve key proposals could lead to severe financial distress, including potential insolvency or delisting.
**Noteholders (Existing & New):** Existing Noteholders who participated in the Exchange Offer received a combination of New Notes and New Shares, addressing their debt repayment obligations prior to maturity. Supporting Noteholders received an additional 'SteerCo Premium'. New Noteholders will hold secured convertible notes with a 7.00% interest rate (9.50% PIK) and significant equity ownership.
**Employees:** The company implemented a Management Incentive Plan (MIP) with RSU and PSU awards to retain and incentivize key employees in light of the substantial dilution. However, the company has also undergone multiple workforce reductions (November 2023, February 2025, August 2025) as part of cost-reduction initiatives, impacting a significant portion of its global workforce.
**Management:** Executive compensation for 2024 saw zero payouts for annual cash incentives and a significant drop in the realizable value of equity awards, reflecting poor company performance. The Restated Equity Incentive Plan and MIP Awards are designed to re-incentivize and retain management amidst the challenging environment and dilution.

Next Steps

Stockholders will vote on five proposals at the Special Meeting on November 19, 2025.
If approved, the Share Increase Amendment would become effective upon filing with the Delaware Secretary of State.
If approved and the board decides to proceed, a reverse stock split would be effected by filing a certificate of amendment, subject to certain timing restrictions.
The company will continue its Global Operations Review, which may include further product line exits, pricing changes, inventory reduction, manufacturing optimization, and workforce reductions.
The company intends to monitor the trading price of its Common Stock on Nasdaq and consider available options to resolve any potential non-compliance with listing rules if the reverse stock split is not approved or implemented.
The human capital management and compensation committee intends to establish stock ownership guidelines for executive officers at an appropriate time in the future.

Key Dates

Date	Description
2009	Beyond Meat's inception.
2011-04-08	Company originally incorporated under the name J Green Natural Foods Co.
2015-06	Dariush Ajami, PhD, joined Beyond Meat.
2017-05	Exclusive supply agreement with a co-manufacturer terminated.
2018-07	Dariush Ajami, PhD, became Chief Innovation Officer.
2019-01	Lubi Kutua served as Vice President, FP&A and Investor Relations.
2019-05	Teri L. Witteman joined Beyond Meat as General Counsel and Secretary.
2019-04-30	2011 Equity Incentive Plan amended and restated as the Existing Plan, effective the day prior to IPO registration statement.
2020-01-01	Start of the fiscal year for which the number of shares reserved for issuance under the Existing Plan automatically increased.
2021-01	Ethan Brown served as a manager of the Planet Partnership, LLC, a joint venture with PepsiCo, Inc.
2021-03-05	Date of Indenture for 0% Convertible Senior Notes due 2027 (Existing Notes).
2021-04	Teri L. Witteman became Chief Legal Officer.
2022	Company pivoted focus toward sustainable long-term growth.
2022-10	Lubi Kutua became Chief Financial Officer and Treasurer.
2022-10-18	Parties to co-manufacturer dispute entered into a confidential settlement agreement.
2023-11-01	Board approved a plan to reduce workforce by approximately 65 employees (19% of global non-production workforce).
2024-01	Jonathan Nelson became Chief Operations Officer.
2024-04	Drew Lufkin joined Beyond Meat as Senior Vice President, Sales.
2024-06	Board authorized and approved the formation of a special transaction committee.
2024-10	Board adopted stock ownership guidelines for outside directors.
2024-10-16	Record date for the Special Meeting (4:00 p.m. Eastern Time).
2024-12-31	End of fiscal year 2024. Closing price of common stock was $3.76 per share.
2025-01-01	Effective date for annual retainer for chair and members of the transaction committee.
2025-02-04	Human capital management and compensation committee determined 0% vesting for Tranche I of 2024 PSUs.
2025-02-24	Board approved a plan to reduce workforce in North America and EU by approximately 44 employees (17% of global non-production workforce).
2025-02-24	Board approved a plan to suspend current operational activities in China, reducing China workforce by approximately 20 employees (95% of China workforce).
2025-05	Human capital management and compensation committee recommended, and board approved, suspension of equity compensation for non-employee directors.
2025-08-06	Management approved a plan to reduce North America workforce by approximately 44 employees (6% of total global workforce).
2025-08	John Boken appointed interim Chief Transformation Officer.
2025-09-27	Number of shares of Common Stock outstanding was 76,751,920.
2025-09-28	Board approved an amendment and restatement of the 2018 Equity Incentive Plan (Restated Plan).
2025-09-28	Board approved 30 alternate amendments for a reverse stock split.
2025-09-29	Company entered into a transaction support agreement with Supporting Noteholders (approx. 47% of Existing Notes).
2025-09-29	Exchange Offer commenced.
2025-09-29	Board granted MIP Awards (RSUs and PSUs) to certain key employees under the Restated Plan.
2025-10-15	Early Settlement Date of the Exchange Offer. Ethan Brown and Nandita Bakhshi resigned from the board. C. James Koch resigned from Class I and appointed to Class II. Alexandre Zyngier and Raphael Thomas Wallander appointed as new directors.
2025-10-16	Closing price of common stock on Nasdaq was $0.52 per share.
2025-10-17	Notice of Special Meeting of Stockholders, proxy statement, and proxy card sent to stockholders.
2025-10-28	Expected expiration of the Exchange Offer, unless extended or terminated earlier.
2025-10-30	Expected date of final settlement of the Exchange Offer (Closing Date).
2025-11-18	Deadline for internet/phone voting (11:59 p.m. Eastern Time).
2025-11-19	Special Meeting of Stockholders to be held virtually at 8:00 a.m. Pacific Time.
2026-01-01	Start of annual increase to share reserve under Restated Plan (commencing January 1, 2027).
2026-01-20	Earliest date for advance notice stockholder proposals for 2026 Annual Meeting.
2026-02-19	Latest date for advance notice stockholder proposals for 2026 Annual Meeting.
2026-12-31	End of the three-year performance period for Tranche III of 2024 PSU awards.
2027-10-15	Maturity date of Existing Notes.
2028-10-15	Date up to which remaining scheduled interest payments on New Notes are calculated for make-whole payments.
2030-10-15	Maturity date of New Notes.
2035-09-28	Termination date of the Restated Plan.

Recommendation

strong sell

The filing reveals a company in significant financial distress, undertaking a highly dilutive debt-for-equity exchange to address impending debt maturities. The resulting dilution is massive, with existing noteholders potentially owning up to 87.7% of the company's common stock. The need for a reverse stock split to maintain Nasdaq listing, coupled with ongoing net losses and a declining revenue trend in a challenging industry, signals fundamental operational and market weaknesses. While cost-cutting measures and improved gross margins are noted, they are insufficient to offset the severe capital structure issues. The zero payout on executive bonuses and the collapse in realizable equity value for management underscore the poor performance. For a seasoned investor, these factors collectively point to a highly speculative investment with substantial downside risk and a 'strong sell' recommendation.

Keywords

Beyond Meat, SEC Filing, Proxy Statement, Debt Exchange, Convertible Notes, Shareholder Dilution, Reverse Stock Split, Authorized Shares, Equity Incentive Plan, Nasdaq Listing, Corporate Governance, Financial Performance, Plant-Based Meat, BYND

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.